BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

75 related articles for article (PubMed ID: 9930320)

  • 21. OX40 costimulation by a chimeric antigen receptor abrogates CD28 and IL-2 induced IL-10 secretion by redirected CD4(+) T cells.
    Hombach AA; Heiders J; Foppe M; Chmielewski M; Abken H
    Oncoimmunology; 2012 Jul; 1(4):458-466. PubMed ID: 22754764
    [TBL] [Abstract][Full Text] [Related]  

  • 22. TCR gene transfer: MAGE-C2/HLA-A2 and MAGE-A3/HLA-DP4 epitopes as melanoma-specific immune targets.
    Straetemans T; van Brakel M; van Steenbergen S; Broertjes M; Drexhage J; Hegmans J; Lambrecht BN; Lamers C; van Der Bruggen P; Coulie PG; Debets R
    Clin Dev Immunol; 2012; 2012():586314. PubMed ID: 22400038
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The cellular protein lyric interacts with HIV-1 Gag.
    Engeland CE; Oberwinkler H; Schümann M; Krause E; Müller GA; Kräusslich HG
    J Virol; 2011 Dec; 85(24):13322-32. PubMed ID: 21957284
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Combination of IL-21 and IL-15 enhances tumour-specific cytotoxicity and cytokine production of TCR-transduced primary T cells.
    Pouw N; Treffers-Westerlaken E; Kraan J; Wittink F; ten Hagen T; Verweij J; Debets R
    Cancer Immunol Immunother; 2010 Jun; 59(6):921-31. PubMed ID: 20101507
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Changing viral tropism using immunoliposomes alters the stability of gene expression: implications for viral vector design.
    Tan PH; Xue SA; Wei B; Holler A; Voss RH; George AJ
    Mol Med; 2007; 13(3-4):216-26. PubMed ID: 17592557
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A recombinant anti-carcinoembryonic antigen immunoreceptor with combined CD3zeta-CD28 signalling targets T cells from colorectal cancer patients against their tumour cells.
    Hombach A; Schlimper C; Sievers E; Frank S; Schild HH; Sauerbruch T; Schmidt-Wolf IG; Abken H
    Gut; 2006 Aug; 55(8):1156-64. PubMed ID: 16188919
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Adoptive immunotherapy of prostate cancer bone lesions using redirected effector lymphocytes.
    Pinthus JH; Waks T; Malina V; Kaufman-Francis K; Harmelin A; Aizenberg I; Kanety H; Ramon J; Eshhar Z
    J Clin Invest; 2004 Dec; 114(12):1774-81. PubMed ID: 15599402
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Use of amplicon-6 vectors derived from human herpesvirus 6 for efficient expression of membrane-associated and -secreted proteins in T cells.
    Borenstein R; Singer O; Moseri A; Frenkel N
    J Virol; 2004 May; 78(9):4730-43. PubMed ID: 15078955
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The genetic modification of T cells for cancer therapy: an overview of laboratory and clinical trials.
    Hwu P; Rosenberg SA
    Cancer Detect Prev; 1994; 18(1):43-50. PubMed ID: 8162605
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Genetically marking human cells--results of the first clinical gene transfer studies.
    Cai Q; Rubin JT; Lotze MT
    Cancer Gene Ther; 1995 Jun; 2(2):125-36. PubMed ID: 7621260
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A retroviral vector system 'STITCH' in combination with an optimized single chain antibody chimeric receptor gene structure allows efficient gene transduction and expression in human T lymphocytes.
    Weijtens ME; Willemsen RA; Hart EH; Bolhuis RL
    Gene Ther; 1998 Sep; 5(9):1195-203. PubMed ID: 9930320
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Process validation and clinical evaluation of a protocol to generate gene-modified T lymphocytes for imunogene therapy for metastatic renal cell carcinoma: GMP-controlled transduction and expansion of patient's T lymphocytes using a carboxy anhydrase IX-specific scFv transgene.
    Lamers CH; van Elzakker P; Langeveld SC; Sleijfer S; Gratama JW
    Cytotherapy; 2006; 8(6):542-53. PubMed ID: 17148030
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Protocol for gene transduction and expansion of human T lymphocytes for clinical immunogene therapy of cancer.
    Lamers CH; Willemsen RA; Luider BA; Debets R; Bolhuis RL
    Cancer Gene Ther; 2002 Jul; 9(7):613-23. PubMed ID: 12082462
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Suspension packaging cell lines for the simplified generation of T-cell receptor encoding retrovirus vector particles.
    Reuss S; Biese P; Cosset FL; Takeuchi Y; Uckert W
    Gene Ther; 2007 Apr; 14(7):595-603. PubMed ID: 17235289
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Gene transfer of human TCR in primary murine T cells is improved by pseudo-typing with amphotropic and ecotropic envelopes.
    Pouw NM; Westerlaken EJ; Willemsen RA; Debets R
    J Gene Med; 2007 Jul; 9(7):561-70. PubMed ID: 17471588
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Expression of chimeric envelope proteins in helper cell lines and integration into Moloney murine leukemia virus particles.
    Schnierle BS; Moritz D; Jeschke M; Groner B
    Gene Ther; 1996 Apr; 3(4):334-42. PubMed ID: 8732165
    [TBL] [Abstract][Full Text] [Related]  

  • 37.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 38.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 39.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.